Medical suicide, more commonly called medical aid in dying, is the practice of a terminally ill patient taking a prescribed lethal medication to end their own life. The term “medical suicide” is informal and sometimes considered outdated by advocates, but it refers to the same process found in laws across more than a dozen countries and eleven U.S. jurisdictions. The key distinction from other end-of-life practices is that the patient, not a doctor, takes the final action.
Terminology and Key Distinctions
Several terms float around this topic, and they don’t all mean the same thing. “Physician-assisted suicide” describes a patient taking a prescribed lethal dose to end their own suffering. “Medical aid in dying” narrows that definition to terminally ill patients choosing a death aligned with their values, regardless of whether they are actively suffering. “Euthanasia” is different entirely: it means a healthcare provider directly administers the lethal medication, rather than the patient taking it themselves.
The distinction matters clinically and legally. In the United States, every jurisdiction that permits the practice requires the patient to self-administer the medication. Canada allows both clinician-administered and self-administered options, though self-administration is extremely rare there, with fewer than seven reported cases. In the Netherlands and Belgium, both forms are legal.
Clinicians also draw a sharp line between aid in dying and suicidality. A patient eligible for medical aid in dying must be terminally ill and choosing the manner of an already-approaching death. When a terminally ill patient is also experiencing active suicidal ideation from depression or another psychiatric condition, providers treat that as a separate clinical situation requiring mental health evaluation.
Who Qualifies
Eligibility requirements are similar across most jurisdictions. The patient must be an adult with an incurable condition likely to result in death within six months (some laws use the phrase “relatively short time”). They must be a resident of the jurisdiction, and they must have the mental capacity to make major medical decisions. In practice, two physicians typically confirm the terminal diagnosis independently.
Mental capacity assessments focus on four abilities: understanding the relevant facts about your illness and prognosis, applying those facts to your own situation, reasoning through alternatives and weighing the pros and cons, and demonstrating a stable, consistent choice over time. If there is any concern that a psychiatric condition like depression is driving the request, clinicians evaluate whether the desire for aid in dying originates from the illness itself or from a treatable mental health condition. A patient whose request stems from depression rather than their terminal prognosis would not be considered eligible.
Where It Is Legal
In the United States, medical aid in dying is legal in Oregon, Washington, California, Colorado, Vermont, New Jersey, Hawaii, Maine, New Mexico, and the District of Columbia. Montana occupies a gray area: a 2009 court ruling established that a physician assisting a terminally ill, mentally competent adult would not face prosecution, but there is no formal law or state oversight.
Internationally, the practice is legal in all six Australian states (though not its two territories), New Zealand (since 2021), Canada, the Netherlands, Belgium, Austria, and Switzerland. The legal frameworks vary significantly. The U.S., Australia, and New Zealand restrict eligibility to terminal diagnoses. The Netherlands, Belgium, and Canada permit it on broader grounds, including intolerable suffering that is not necessarily tied to a terminal timeline.
Why Patients Request It
The reasons people seek medical aid in dying are often not what you might expect. A Canadian study of 112 patients who received assisted deaths found that disease-related symptoms like pain and nausea were the top reason, cited by about 60% of patients. But close behind were loss of control and independence (53%), loss of ability to enjoy meaningful activities (49%), and fear of future suffering (24%). Only about 4% cited a previous negative experience watching someone else die.
This pattern holds in Oregon, which has tracked data since 1997. Research consistently shows that requests are driven less by current physical pain and more by concerns about autonomy, dignity, and the ability to participate in life. The typical patient in Oregon’s 2023 data was white, 75 years old, and had a cancer diagnosis. Of the 367 people who died under the law that year, 66% had cancer, 11% had neurological disease, and 10% had heart or circulatory disease.
How the Process Works
In U.S. states, the process begins with an oral request to a physician, followed by a written request, and then a second oral request after a mandatory waiting period. Two physicians must independently confirm the terminal diagnosis and the patient’s mental capacity. If either physician suspects impaired judgment from depression or another condition, a mental health evaluation is required before proceeding.
Once approved, the physician writes a prescription. The patient fills it and decides when, or whether, to take it. In Oregon, 560 people received prescriptions in 2023, but only 367 actually took the medication. A significant number of patients each year obtain the prescription and never use it. For many, simply having the option provides a sense of control.
In jurisdictions where clinician administration is permitted, like Canada, the standard protocol involves a sequence of medications given intravenously: first a sedative to reduce anxiety, then an anesthetic to induce deep unconsciousness, followed by a medication that stops breathing. Death typically occurs within minutes. The patient must provide final consent immediately before administration, meaning they must be fully conscious and capable at that moment.
How It Differs From Palliative Sedation
Palliative sedation is a separate practice sometimes confused with medical aid in dying. In palliative sedation, a patient with intractable symptoms like severe pain, difficulty breathing, or delirium is given progressively increasing sedation to relieve suffering, sometimes to the point of unconsciousness. The goal is symptom relief, not death, and the medication is carefully adjusted in proportion to symptoms.
Several practical differences separate the two. Palliative sedation is typically considered when death is expected within two weeks or less, and it does not require the patient’s real-time consent since patients in this situation have often already lost the ability to communicate. Medical aid in dying, by contrast, requires the patient to be fully capable of consenting at the moment the medication is taken or administered. Palliative sedation is available in essentially every healthcare setting, while aid in dying is only legal in specific jurisdictions.
Another option some patients choose is voluntarily stopping eating and drinking, which does not require a prescription or legal authorization. This process typically leads to death over one to two weeks and is supported by hospice care to manage discomfort during that time.
The Medical Ethics Debate
The American Medical Association holds that physician-assisted suicide is “fundamentally inconsistent with the physician’s professional role.” The AMA’s position is that requests for aid in dying should signal to physicians that a patient’s needs are unmet, prompting further evaluation of what is driving the suffering. The organization advocates for more aggressive comfort care, hospice involvement, and psychiatric evaluation for terminally ill patients rather than assisted death.
Other medical organizations take different positions. The American Academy of Family Physicians has adopted a stance of “engaged neutrality,” neither supporting nor opposing the practice but encouraging physicians to be present for patients navigating end-of-life decisions. In jurisdictions where aid in dying is legal, no physician is required to participate. Conscience protections allow doctors who object to decline involvement and refer patients to willing providers.
Supporters argue that aid in dying respects patient autonomy and provides a compassionate option for people facing an inevitable, often painful death. Opponents worry about potential pressure on vulnerable patients, the possibility of diagnostic errors in predicting a six-month prognosis, and the broader societal implications of normalizing physician involvement in hastening death. Both sides generally agree that improving access to high-quality palliative care is essential regardless of one’s position on assisted dying.